Berry Goes Beyond Drug Delivery at DDL 2023

Name: Berry Global, Inc.
Address: 101 Oakley Street, Evansville, Indiana, 47710
Telephone: +1 (877) 662-3779
Price range: £000 - £0000000

November 23, 2023

Inhalation solutions that deliver a better patient experience, including improved adherence and administration, will be showcased by Berry Global at this year’s DDL Conference.

Leveraging the company’s sustainable design expertise and over 50 years of experience in the development of respiratory drug delivery devices, the new inhalation products help deliver a better healthcare experience by improving quality of care while helping to reduce costs and supporting the circular economy.

At the conference, Berry will show a range of models from its extensive portfolio of dry powder inhalers (DPIs), pressurized metered dose inhalers (pMDIs) with or without dose indicators, breath-actuated inhalers, and digital inhalers.

A major highlight on the stand will be the company’s newly launched PneumoHaler, a lightweight, breath-actuated, multi-dose inhaler with a dose indicator for the effective management of asthma and chronic obstructive pulmonary disease (COPD). Designed to provide a ready-to-use solution for new inhalation treatments, the PneumoHaler eliminates the need for pharmaceutical companies to develop their own platforms, enabling the delivery of faster-to-market solutions. Equally important, the PneumoHaler helps enhance medication adherence caused by poor user technique of pMDIs.

Significant recent introductions in Berry’s DPI range include the RS01-X single-dose DPI with built-in sensors and digital services to track inhaler use and help improve adherence and technique, and the RS01 Size 2 capsule-based inhaler, which meets the increased demand for higher dose devices for the pulmonary delivery of systemic treatments and highly engineered, low-density powder formulations.

Berry will also demonstrate its market leadership in the CDMO of customized devices based on customers’ IP. Both standard and bespoke solutions can be developed and supplied from the company’s three facilities in Osnago (Italy), Mellrichstadt (Germany), and Bengaluru (Bangalore, India), providing a global reach and fast response.

“At Berry, we think Beyond Drug Delivery, and we help our customers Do Better, By Dosing better,” said Arturo Cubí, Business Development Director – Global Healthcare for Berry Global.

“This is our commitment to create patient-centric drug delivery inhalation solutions that enhance the user experience, improve disease management, and minimize environmental impact. We look forward to discussing customers’ specific requirements during DDL 2023.”

Learn more about the products and solutions offered in the global healthcare market.

News & Insights

Berry Global Invests to Increase Production Capacity for Healthcare Products

Berry Global Group, Inc., a leader in the design, development, and production of patient-centred healthcare solutions, has invested in additional assets and manufacturing capabilities to increase its healthcare production capacity by up to 30% across three of its European sites.
Following the opening of its manufacturing facility and healthcare center of excellence in Bangalore, India, these latest investments underline Berry’s commitment to delivering high-quality packaging and drug delivery devices that enhance the patient experience through improved medicine administration and adherence.

Berry’s Dual Chamber Inhaler Enables Access to Combination Drugs

Berry Global, a leader in the design, development, and production of patient-centred healthcare solutions, recently launched the BerryHaler, a dual chamber, dry powder inhaler (DPI) with a dose counter designed to provide better patient access to and support the effective delivery of combination drugs.

Berry Acquires F&S Tool Inc., Expands Full Plastic Packaging Lifecycle Solutions for Customers

Berry Global Group, Inc. (NYSE: BERY) announces its acquisition of F&S Tool, a specialized provider of high output, high-efficiency hot runner injection and high-volume compression molding applications. This acquisition will further enhance Berry’s global tooling capability as well as bring proprietary technologies in the closures and bottles space, specifically targeting high-end growth markets.

Berry Global Again Recognized by CDP for Climate Leadership and Supplier Engagement

Global packaging leader Berry Global Group, Inc. has again earned prestigious Climate Change and Supplier Engagement “A-” ratings from global sustainability disclosure non-profit, CDP. The company's prioritization of climate action and supply chain transparency – above both global and North American regional averages – places it among the top 18% and 15%, respectively, of plastic product manufacturers to reach the “Leadership” band. Calculated based on environmental disclosure and performance, CDP ratings underscore Berry’s commitment to working with its suppliers to achieve net-zero emissions across its global operations and value chain by 2050.

Let us serve you

If you'd prefer to call us: +1 (877) 662-3779
Contact information for our global facilities can be found via our locations page.

Tell us more about how we can serve you so we can connect you with the right person.

*Required for details, read our Privacy and Cookies Policy